Latigo Biotech Files for $288M Nasdaq IPO to Fund Non-Opioid Pain Drugs
Latigo files for $288M US IPO to advance its non-opioid painkiller pipeline, capitalizing on strong investor interest in safer alternatives to addictive…
Latigo files for $288M US IPO to advance its non-opioid painkiller pipeline, capitalizing on strong investor interest in safer alternatives to addictive…
A hedge fund with $1.1 billion in Bitcoin miner stocks is seeking new capital after leveraged AI bets soured in July’s tech…
Jersey Mike’s raised $1 billion in its IPO, pricing at the top of the range and underscoring strong investor appetite for consumer…
Quanta Computer’s $2.2 billion equity offering seeks to capitalize on AI server demand, benefiting Nvidia’s chip production while pressuring Quanta shares.
Elevate Campuses readies $267 million India IPO for August, aiming to tap education demand and potentially moving Nifty 50 and the rupee.
Gold miner Cadillac seeks $258 million in a Canadian IPO, aiming to leverage high gold prices and investor interest in mining stocks…
Goldman Sachs issues preferred shares to exploit the lowest credit spreads in over a decade, offering high-yield bank paper while potentially weighing…
Indian dairy company Milky Mist prepares to raise $213 million through an IPO set to launch this month, boosting equity market activity.
Welltower launches a C$750 million Canadian-dollar corporate bond sale, highlighting cross-border funding opportunities and potential impacts on the loonie and Canadian credit…
Unimicron's $1.4 billion GDS offering fuels expansion of its Nvidia chip substrate business, lifting outlook for Taiwan's semiconductor sector.
India's IPO market is on track to break records in 2026 as a robust pipeline and strong investor demand offset a slow…
South Korea's largest memory chip maker seeks $30 billion in a U.S. stock offering, highlighting the semiconductor industry's capital-intensive push to meet…